Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Jan;79(1):3–4. doi: 10.1136/bjo.79.1.3-a

Latanoprost--a promising new glaucoma drug.

S Nagasubramanian
PMCID: PMC505007  PMID: 7880788

Full text

PDF
3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alm A., Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 1991 Nov;109(11):1564–1568. doi: 10.1001/archopht.1991.01080110100045. [DOI] [PubMed] [Google Scholar]
  2. Alm A., Villumsen J., Törnquist P., Mandahl A., Airaksinen J., Tuulonen A., Marsk A., Resul B., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology. 1993 Sep;100(9):1312–1317. doi: 10.1016/s0161-6420(93)31482-x. [DOI] [PubMed] [Google Scholar]
  3. Bito L. Z., Camras C. B., Gum G. G., Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. Prog Clin Biol Res. 1989;312:349–368. [PubMed] [Google Scholar]
  4. Camras C. B., Schumer R. A., Marsk A., Lustgarten J. S., Serle J. B., Stjernschantz J., Bito L. Z., Podos S. M. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension. Arch Ophthalmol. 1992 Dec;110(12):1733–1738. doi: 10.1001/archopht.1992.01080240073034. [DOI] [PubMed] [Google Scholar]
  5. Camras C. B., Siebold E. C., Lustgarten J. S., Serle J. B., Frisch S. C., Podos S. M., Bito L. Z. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology. 1989 Sep;96(9):1329–1337. doi: 10.1016/s0161-6420(89)32717-5. [DOI] [PubMed] [Google Scholar]
  6. Giuffrè G. The effects of prostaglandin F2 alpha in the human eye. Graefes Arch Clin Exp Ophthalmol. 1985;222(3):139–141. doi: 10.1007/BF02173538. [DOI] [PubMed] [Google Scholar]
  7. Lee P. Y., Shao H., Camras C. B., Podos S. M. Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients. Ophthalmology. 1991 Jul;98(7):1079–1082. doi: 10.1016/s0161-6420(91)32173-0. [DOI] [PubMed] [Google Scholar]
  8. Lee P. Y., Shao H., Xu L. A., Qu C. K. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects. Invest Ophthalmol Vis Sci. 1988 Oct;29(10):1474–1477. [PubMed] [Google Scholar]
  9. Nagasubramanian S., Sheth G. P., Hitchings R. A., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens. Ophthalmology. 1993 Sep;100(9):1305–1311. doi: 10.1016/s0161-6420(13)31817-x. [DOI] [PubMed] [Google Scholar]
  10. Rácz P., Ruzsonyi M. R., Nagy Z. T., Bito L. Z. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study. Arch Ophthalmol. 1993 May;111(5):657–661. doi: 10.1001/archopht.1993.01090050091036. [DOI] [PubMed] [Google Scholar]
  11. Toris C. B., Camras C. B., Yablonski M. E. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993 Sep;100(9):1297–1304. doi: 10.1016/s0161-6420(93)31484-3. [DOI] [PubMed] [Google Scholar]
  12. Villumsen J., Alm A. Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes. Acta Ophthalmol (Copenh) 1990 Jun;68(3):341–343. doi: 10.1111/j.1755-3768.1990.tb01935.x. [DOI] [PubMed] [Google Scholar]
  13. Villumsen J., Alm A. PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension. Br J Ophthalmol. 1992 Apr;76(4):214–217. doi: 10.1136/bjo.76.4.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Villumsen J., Alm A. Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol. 1989 Jun;73(6):419–426. doi: 10.1136/bjo.73.6.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Villumsen J., Alm A., Söderström M. Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma. Br J Ophthalmol. 1989 Dec;73(12):975–979. doi: 10.1136/bjo.73.12.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Villumsen J., Alm A. The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma. Arch Ophthalmol. 1990 Aug;108(8):1102–1105. doi: 10.1001/archopht.1990.01070100058034. [DOI] [PubMed] [Google Scholar]
  17. Ziai N., Dolan J. W., Kacere R. D., Brubaker R. F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 1993 Oct;111(10):1351–1358. doi: 10.1001/archopht.1993.01090100059027. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES